Home Press Release Pharmaceutical company observes Vigilance Awareness Week 2023 to ensure ethical practices

Pharmaceutical company observes Vigilance Awareness Week 2023 to ensure ethical practices

790
0
SHARE
 
Cadila Pharmaceuticals Ltd (CPL) proudly inaugurated the Vigilance Awareness Week on 30.10.23 at Bhat, Ahmedabad Corporate Office, marking a significant milestone as the first pharmaceutical company to observe such an event. This initiative exemplifies CPL’s unwavering commitment to upholding the highest ethical standards in its business operations.
The highlight of the week’s commencement was the Integrity Pledge taken by CPL employees, reinforcing the company’s dedication to ethical conduct and vigilance in all aspects of its operations. The Vigilance Forensic and Security (VFS) Department, an integral part of CPL, oversees vigilance, integrity, and ethical practices within the organization, ensuring transparency and good governance.
CPL employees also signed a signboard during the observance, symbolizing their firm commitment to maintaining high ethical values within the company. This symbolic act further underlines CPL’s dedication to fostering a culture of integrity and good governance.
Vigilance Awareness Week is not just about ceremony but also a platform for action. The VFS Department at CPL has devised a comprehensive plan for the week, featuring various activities that celebrate employees who have displayed exceptional commitment to ethical behavior and preventive vigilance practices. Moreover, the VFS Department actively encourages all Cadila employees to share their insights, experiences, and recommendations regarding ethical practices, aiming to enhance proactive vigilance efforts and collectively establish exemplary standards in ethics, integrity, and good governance.
The motto for Cadila’s Vigilance Awareness Week is “Be Vigilant and Commit to the Nation,” a powerful reminder of the company’s dedication to contributing to the greater good of the nation. This initiative not only sets a precedent in the pharmaceutical industry but also reaffirms Cadila Pharmaceuticals Ltd.’s pledge to conduct business with the utmost integrity.

 

 

Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content.